Citadel Advisors
HIMS icon

Citadel Advisors’s Hims & Hers Health HIMS Stock Holding History

Citadel Advisors’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$144M Buy
6,915,700
+2,464,900
+55% +$58.2M 0.02% 610
2025
Q4 		$145M Sell
4,450,800
-2,025,000
-31% -$86.7M 0.02% 646
2025
Q3 		$367M Buy
6,475,800
+3,515,200
+119% +$180M 0.06% 267
2025
Q2 		$148M Buy
2,960,600
+206,900
+8% +$9.35M 0.03% 532
2025
Q1 		$81.4M Sell
2,753,700
-157,900
-5% -$5.87M 0.02% 819
2024
Q4 		$70.4M Buy
2,911,600
+1,686,900
+138% +$41.8M 0.01% 990
2024
Q3 		$22.6M Sell
1,224,700
-237,900
-16% -$4.26M ﹤0.01% 1919
2024
Q2 		$29.5M Buy
1,462,600
+966,900
+195% +$16.1M 0.01% 1620
2024
Q1 		$7.67M Buy
495,700
+339,500
+217% +$3.83M ﹤0.01% 3316
2023
Q4 		$1.39M Buy
156,200
+8,400
+6% +$62.1K ﹤0.01% 6029
2023
Q3 		$930K Sell
147,800
-35,000
-19% -$260K ﹤0.01% 6715
2023
Q2 		$1.72M Buy
182,800
+50,500
+38% +$501K ﹤0.01% 5431
2023
Q1 		$1.31M Sell
132,300
-500
-0.4% -$4.38K ﹤0.01% 6209
2022
Q4 		$851K Sell
132,800
-68,200
-34% -$388K ﹤0.01% 7127
2022
Q3 		$1.12M Buy
201,000
+33,900
+20% +$204K ﹤0.01% 6739
2022
Q2 		$757K Buy
167,100
+33,200
+25% +$142K ﹤0.01% 7668
2022
Q1 		$714K Sell
133,900
-27,500
-17% -$136K ﹤0.01% 8517
2021
Q4 		$1.06M Sell
161,400
-109,900
-41% -$795K ﹤0.01% 7812
2021
Q3 		$2.05M Buy
271,300
+90,100
+50% +$763K ﹤0.01% 6286
2021
Q2 		$1.97M Sell
181,200
-12,300
-6% -$146K ﹤0.01% 6655
2021
Q1 		$2.56M Buy
+193,500
New +$3.24M ﹤0.01% 5806

Other funds holding HIMS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DE
Defiance ETFs New York $6.98B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citadel Advisors's HIMS Position: Q1 2026 in Review

Citadel Advisors reduced its Hims & Hers Health (HIMS) stake by 65% in Q1 2026, selling an estimated $29.9M and leaving 694,774 shares worth $14.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2733.

Citadel Advisors first reported a position in HIMS in Q1 2021 and has held it in 20 quarters since. The position peaked at $63.6M in Q4 2025. 434 funds tracked by Wall St. Rank hold HIMS as of Q1 2026.

  • Citadel Advisors held 694,774 shares of Hims & Hers Health worth $14.4M as of Q1 2026.
  • Citadel Advisors sold 1,265,136 Hims & Hers Health shares in Q1 2026, an estimated $29.9M.
  • Hims & Hers Health made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #2733 holding.
  • Citadel Advisors first reported a position in Hims & Hers Health in Q1 2021 and has held it in 20 quarters since.
  • Citadel Advisors's Hims & Hers Health position peaked at $63.6M in Q4 2025.
  • 434 funds tracked by Wall St. Rank held Hims & Hers Health as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.